Global Myelodysplastic Syndrome Market Analysis 2016-2017, Trends, Size and Forecasts 2018-2024 - CAGR to Grow at 12.3% - ResearchAndMarkets.com

DUBLIN--()--The "Myelodysplastic Syndrome Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global myelodysplastic syndrome market to grow with a CAGR of 12.3% over the forecast period of 2018-2024. The study on myelodysplastic syndrome market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The report on myelodysplastic syndrome market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global myelodysplastic syndrome market over the period of 2016 to 2024.

Key Topics Covered

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

3. Global Myelodysplastic Syndrome Market Overview

3.1. Introduction

3.2. Market Dynamics

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.5. Competitive Landscape in the Global Myelodysplastic Syndrome Market

4. Global Myelodysplastic Syndrome Market by Route of Administration

4.1. Parenteral

4.2. Oral

5. Global Myelodysplastic Syndrome Market by Drug Class

5.1. Cytotoxic Antibiotics

5.2. Topoisomerase Inhibitors

5.3. Alkylating Agents

5.4. Others

6. Global Myelodysplastic Syndrome Market by Region 2018-2024

6.1. North America

6.2. Europe

6.3. Asia-Pacific

6.4. RoW

7. Companies Covered

7.1. Bellicum Pharmaceuticals

7.2. Eli-lilly

7.3. Celator Pharmaceuticals

7.4. Celgene

7.5. Biolinerx

7.6. Novartis

7.7. Cornerstone Pharmaceuticals

7.8. Glaxosmithkline

7.9. Acceleron Pharma

7.10. Amgen

For more information about this report visit https://www.researchandmarkets.com/research/ftsgfz/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Leukemia Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Leukemia Drugs